Noninvasive continuous glucose monitoring using photoacoustic technology - Results from the first 62 subjects

Diabetes Technology and Therapeutics

Volumn 9, Issue 1, 2007, Pages 68-74

  Weiss, Ram ^a   Yegorchikov, Yevgeny ^b   Shusterman, Alexander ^b   Raz, Itamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Glucon Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTICS; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PHOTOACOUSTICS; PRIORITY JOURNAL;

ADULT; BLOOD; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED;

EID: 33847225922     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.0059     Document Type: Article

References (10)

1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
2. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-389. Erratum in: N Engl J Med 2000;342:1376.
3. Weinzimer SA, Doyle EA, Tamborlane WV Jr: Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies. Clin Pediatr 2005;44:393-403.
4. Davidson J: Strategies for improving glycemic control: effective use of glucose monitoring. Am J Med 2005;118(Suppl 9A):27S-32S.
5. Landgraf R: The relationship of postprandial glucose to HbA1c. Diabetes Metab Res Rev 2004;20(Suppl 2):S9-S12.
6. Klonoff DC: Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005;28:1231-1239.
7. Steil GM, Panteleon AE, Rebrin K: Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 2004;56:125-144.
8. Weiss R, Yegorchikov Y, Shusterman A, Raz I: Non invasive continuous glucose monitoring-results from the first 62 subjects [abstract 408-P]. http://scientificsessions.diabetes.org/Abstracts/index.cfm?fuseaction=Locator. PreviewAbstract&popup=yes&No-Layout=Yes&AbstractID=13405 (accessed November 20, 2006).
9. Nagar R, Pesach B, Ben-Ami U, inventors; Glucon Inc., assignee: Photoacoustic assay and imaging system. US Patent 6,846,288. January 25, 2005.
10. Koschinsky T, Jungheim K, Heinemann L: Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther 2003;5:829-842.